Wada, F., Koga, H., Akiba, J., Niizeki, T., Iwamoto, H., Ikezono, Y., . . . Torimura, T. (2018). High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine. Cancer Sci.
استشهاد بنمط شيكاغوWada, Fumitaka, et al. "High Expression of CD44v9 and XCT in Chemoresistant Hepatocellular Carcinoma: Potential Targets By Sulfasalazine." Cancer Sci 2018.
MLA استشهادWada, Fumitaka, et al. "High Expression of CD44v9 and XCT in Chemoresistant Hepatocellular Carcinoma: Potential Targets By Sulfasalazine." Cancer Sci 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.